ATE455768T1 - Triazolsubstituierte aminobenzophenonverbindungen - Google Patents
Triazolsubstituierte aminobenzophenonverbindungenInfo
- Publication number
- ATE455768T1 ATE455768T1 AT05804019T AT05804019T ATE455768T1 AT E455768 T1 ATE455768 T1 AT E455768T1 AT 05804019 T AT05804019 T AT 05804019T AT 05804019 T AT05804019 T AT 05804019T AT E455768 T1 ATE455768 T1 AT E455768T1
- Authority
- AT
- Austria
- Prior art keywords
- triazole substituted
- aminobenzophenone compounds
- substituted aminobenzophenone
- compounds
- triazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63500004P | 2004-12-13 | 2004-12-13 | |
DKPA200401942 | 2004-12-16 | ||
PCT/DK2005/000757 WO2006063585A1 (en) | 2004-12-13 | 2005-11-28 | Triazole substituted aminobenzophenone compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE455768T1 true ATE455768T1 (de) | 2010-02-15 |
Family
ID=37715934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05804019T ATE455768T1 (de) | 2004-12-13 | 2005-11-28 | Triazolsubstituierte aminobenzophenonverbindungen |
Country Status (23)
Country | Link |
---|---|
US (1) | US8293772B2 (de) |
EP (1) | EP1828148B1 (de) |
JP (1) | JP5015005B2 (de) |
KR (1) | KR101260236B1 (de) |
CN (1) | CN101115728B (de) |
AR (1) | AR051792A1 (de) |
AT (1) | ATE455768T1 (de) |
AU (1) | AU2005316034B2 (de) |
BR (1) | BRPI0518993A2 (de) |
CA (1) | CA2590479A1 (de) |
DE (1) | DE602005019093D1 (de) |
DK (1) | DK1828148T3 (de) |
ES (1) | ES2341473T3 (de) |
HR (1) | HRP20100225T1 (de) |
IL (1) | IL183513A0 (de) |
MX (1) | MX2007006739A (de) |
NO (1) | NO20073574L (de) |
PL (1) | PL1828148T3 (de) |
PT (1) | PT1828148E (de) |
RU (1) | RU2394818C2 (de) |
UA (1) | UA90698C2 (de) |
WO (1) | WO2006063585A1 (de) |
ZA (1) | ZA200704809B (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101048279B1 (ko) * | 2002-05-30 | 2011-07-13 | 더 스크립스 리서치 인스티튜트 | 구리 촉매 작용하에서의 아지드와 아세틸렌과의 리게이션 |
US20100069609A1 (en) * | 2006-06-21 | 2010-03-18 | Erik Arstad | Chemical methods and apparatus |
US8080540B2 (en) | 2006-09-19 | 2011-12-20 | Abbott Products Gmbh | Therapeutically active triazoles and their use |
KR100932093B1 (ko) | 2006-09-27 | 2009-12-16 | 주식회사종근당 | 미세소관 형성 저해제로서 유용한 벤조페논 유도체 |
US8288367B2 (en) | 2006-11-30 | 2012-10-16 | Solvay Pharmaceuticals Gmbh | Substituted estratriene derivatives as 17BETA HSD inhibitors |
ATE520689T1 (de) * | 2007-12-18 | 2011-09-15 | Actelion Pharmaceuticals Ltd | Aminotriazolderivate als alx-agonisten |
DK2272845T3 (en) * | 2008-03-26 | 2015-05-04 | Chong Kun Dang Pharm Corp | Benzophenone Thiazole Derivatives for Inhibiting Microtubule Formation and Method for Preparation thereof |
US9029408B2 (en) | 2008-06-16 | 2015-05-12 | Gtx, Inc. | Compounds for treatment of cancer |
US8822513B2 (en) | 2010-03-01 | 2014-09-02 | Gtx, Inc. | Compounds for treatment of cancer |
DK3289876T3 (da) | 2008-06-16 | 2022-10-10 | Univ Tennessee Res Found | Forbindelser til behandling af cancer |
US9447049B2 (en) | 2010-03-01 | 2016-09-20 | University Of Tennessee Research Foundation | Compounds for treatment of cancer |
US20120322776A1 (en) | 2009-12-22 | 2012-12-20 | Leo Pharma A/S | Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants |
ES2452872T3 (es) | 2009-12-22 | 2014-04-03 | Leo Pharma A/S | Composición farmacéutica que comprende una mezcla solvente y un derivado o análogo de vitamina D |
JP5816194B2 (ja) | 2009-12-22 | 2015-11-18 | レオ ファーマ アクティーゼルスカブ | カルシポトリオール一水和物ナノクリスタル |
US8912184B1 (en) | 2010-03-01 | 2014-12-16 | Alzheimer's Institute Of America, Inc. | Therapeutic and diagnostic methods |
EP2542081A4 (de) | 2010-03-01 | 2013-07-31 | Gtx Inc | Verbindungen zur krebsbehandlung |
KR101666759B1 (ko) * | 2015-08-06 | 2016-10-18 | 경북대학교 산학협력단 | 1-벤조피란메틸-1h-1,2,3-트리아졸 유도체 및 이의 용도 |
CN106632285B (zh) * | 2016-11-23 | 2019-11-01 | 河南师范大学 | 一种齐多夫定-1,2,3-三氮唑类化合物的合成方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9701453D0 (en) * | 1997-01-24 | 1997-03-12 | Leo Pharm Prod Ltd | Aminobenzophenones |
EP1202959B1 (de) | 1999-07-16 | 2004-09-29 | Leo Pharma A/S | Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha |
CA2379319A1 (en) | 1999-07-16 | 2001-01-25 | Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsa Ktieselskab) | Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
RU2247719C2 (ru) | 1999-07-16 | 2005-03-10 | Лео Фармасьютикал Продактс Лтд.А/С (Левенс Кемиске Фабрик Продукционсактиесельскаб) | Аминобензофеноны как ингибиторы il-1 бета и tnf-альфа, фармацевтическая композиция и способ лечения и/или профилактики воспалительных заболеваний |
ATE277891T1 (de) | 1999-07-16 | 2004-10-15 | Leo Pharma As | Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha |
CN1231459C (zh) | 1999-07-16 | 2005-12-14 | 里奥药物制品有限公司 | 新型氨基二苯酮 |
KR20020071876A (ko) * | 1999-12-06 | 2002-09-13 | 레오 파마 에이/에스 | IL-1β 및 TNF-α의 억제제로서의 아미노벤조페논 |
BR0111034A (pt) | 2000-05-22 | 2003-06-17 | Leo Pharma S A | Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou doenças inflamatórias, para o tratamento e/ou profilaxia de osteoporose e para o tratamento de doenças relacionadas à aids |
GB0107368D0 (en) * | 2001-03-23 | 2001-05-16 | Novartis Ag | Organic compounds |
WO2002083622A2 (en) | 2001-04-10 | 2002-10-24 | Leo Pharma A/S | Novel aminophenyl ketone derivatives |
MXPA04001912A (es) | 2001-08-28 | 2004-07-23 | Leo Pharma As | Aminobenzofenonas novedosas. |
PL377377A1 (pl) | 2002-12-20 | 2006-02-06 | Leo Pharma A/S | Nowe związki aminobenzofenonu |
CA2530302C (en) * | 2003-07-24 | 2013-12-03 | Leo Pharma A/S | Novel aminobenzophenone compounds |
US20090313239A1 (en) | 2008-06-16 | 2009-12-17 | Microsoft Corporation | Adaptive Visual Similarity for Text-Based Image Search Results Re-ranking |
-
2005
- 2005-11-28 MX MX2007006739A patent/MX2007006739A/es active IP Right Grant
- 2005-11-28 ZA ZA200704809A patent/ZA200704809B/xx unknown
- 2005-11-28 AU AU2005316034A patent/AU2005316034B2/en not_active Ceased
- 2005-11-28 CN CN2005800480385A patent/CN101115728B/zh not_active Expired - Fee Related
- 2005-11-28 ES ES05804019T patent/ES2341473T3/es active Active
- 2005-11-28 PL PL05804019T patent/PL1828148T3/pl unknown
- 2005-11-28 RU RU2007126648/04A patent/RU2394818C2/ru not_active IP Right Cessation
- 2005-11-28 JP JP2007545836A patent/JP5015005B2/ja not_active Expired - Fee Related
- 2005-11-28 DK DK05804019.7T patent/DK1828148T3/da active
- 2005-11-28 CA CA002590479A patent/CA2590479A1/en not_active Abandoned
- 2005-11-28 AT AT05804019T patent/ATE455768T1/de active
- 2005-11-28 KR KR1020077015959A patent/KR101260236B1/ko not_active IP Right Cessation
- 2005-11-28 BR BRPI0518993-4A patent/BRPI0518993A2/pt not_active IP Right Cessation
- 2005-11-28 PT PT05804019T patent/PT1828148E/pt unknown
- 2005-11-28 DE DE602005019093T patent/DE602005019093D1/de active Active
- 2005-11-28 EP EP05804019A patent/EP1828148B1/de active Active
- 2005-11-28 UA UAA200707890A patent/UA90698C2/ru unknown
- 2005-11-28 WO PCT/DK2005/000757 patent/WO2006063585A1/en active Application Filing
- 2005-12-02 US US11/292,064 patent/US8293772B2/en not_active Expired - Fee Related
- 2005-12-12 AR ARP050105193A patent/AR051792A1/es not_active Application Discontinuation
-
2007
- 2007-05-29 IL IL183513A patent/IL183513A0/en unknown
- 2007-07-10 NO NO20073574A patent/NO20073574L/no not_active Application Discontinuation
-
2010
- 2010-04-19 HR HR20100225T patent/HRP20100225T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
PL1828148T3 (pl) | 2010-08-31 |
RU2007126648A (ru) | 2009-01-20 |
CN101115728B (zh) | 2012-12-19 |
DE602005019093D1 (de) | 2010-03-11 |
HRP20100225T1 (hr) | 2010-07-31 |
US8293772B2 (en) | 2012-10-23 |
ZA200704809B (en) | 2008-08-27 |
CA2590479A1 (en) | 2006-06-22 |
CN101115728A (zh) | 2008-01-30 |
EP1828148B1 (de) | 2010-01-20 |
DK1828148T3 (da) | 2010-05-17 |
ES2341473T3 (es) | 2010-06-21 |
AR051792A1 (es) | 2007-02-07 |
IL183513A0 (en) | 2007-09-20 |
UA90698C2 (en) | 2010-05-25 |
BRPI0518993A2 (pt) | 2008-12-23 |
EP1828148A1 (de) | 2007-09-05 |
US20060128766A1 (en) | 2006-06-15 |
KR101260236B1 (ko) | 2013-05-06 |
RU2394818C2 (ru) | 2010-07-20 |
MX2007006739A (es) | 2007-08-02 |
NO20073574L (no) | 2007-07-10 |
WO2006063585A1 (en) | 2006-06-22 |
AU2005316034A1 (en) | 2006-06-22 |
AU2005316034B2 (en) | 2012-01-19 |
PT1828148E (pt) | 2010-05-04 |
JP2008523115A (ja) | 2008-07-03 |
JP5015005B2 (ja) | 2012-08-29 |
KR20070095945A (ko) | 2007-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE455768T1 (de) | Triazolsubstituierte aminobenzophenonverbindungen | |
DK1605897T3 (da) | Polyethelen-glycol-link-glp-1-forbindelser | |
IS8323A (is) | Ný amínóbensófenónefnasambönd | |
ATE404546T1 (de) | Substituierte n-sulfonylaminobenzyl-2- phenoxyacetamidverbindungen | |
IS8089A (is) | Efnasambönd | |
ITMI20042238A1 (it) | Composti per fluoropolirterei | |
DE502005008002D1 (de) | Bleichmittel-mischungen | |
NO20031736D0 (no) | Forbindelser | |
ATE384719T1 (de) | Dioxazinyl-substituierte thienylsulfonylaminocarbonylverbindungen | |
SE0400022D0 (sv) | New compounds | |
SE0402103D0 (sv) | Novel compounds | |
ATE373956T1 (de) | Fungizide mischungen | |
SE0400254D0 (sv) | New compounds | |
SE0402391D0 (sv) | Novelheterocyclic compounds | |
DOP2004000959A (es) | Compuestos | |
HK1117152A1 (en) | Triazole substituted aminobenzophenone compounds | |
SI1828148T1 (sl) | S triazolom nadomeĺ äśeni aminobenzofenonski sestavki | |
SE0401658D0 (sv) | New compounds | |
SE0401667D0 (sv) | New compounds | |
SE0402509D0 (sv) | New compounds | |
SE0401332D0 (sv) | New compounds | |
SE0402681D0 (sv) | New compounds | |
SE0401324D0 (sv) | New compounds | |
SE0400227D0 (sv) | New compounds | |
SE0400102D0 (sv) | New compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1828148 Country of ref document: EP |